Skip to main content
Fig. 4 | Journal of Experimental & Clinical Cancer Research

Fig. 4

From: The comparison of clinical and biological characteristics between IDH1 and IDH2 mutations in gliomas

Fig. 4

The Kaplan–Meier estimates for Overall survival (OS) (a) and Progression-free survival (PFS) (b) indicates that IDH2 mutant gliomas associated with longer overall survival (p = 0.011) and longer progression-free survival (p = 0.011) than IDH1/2 wild-type gliomas. However, the OS and PFS did not significantly differ between IDH1 mutant and IDH2 mutant gliomas

Back to article page